Glaukos Corporation
NYSE GKOS · Aliso Viejo, CA
Works in Ophthalmology
Glaukos Corporation is a clinical trial sponsor based in Aliso Viejo, CA, listed as NYSE GKOS. It has 11 active clinical trials with 1,656 planned participants, in Ophthalmology. Since 2021 it has completed 27 trials and stopped 7 early.
Trial track record · since 2021
Financials · NYSE GKOS
Pipeline · 11 active trials
| Stage | Trial | Status |
|---|---|---|
On the market
4 approved drug applications with a product on the market.
Questions about Glaukos Corporation
Glaukos Corporation is lead sponsor of 11 active clinical trials on ClinicalTrials.gov, with 1,656 planned participants, in Ophthalmology. Since 2021 it has completed 27 trials and stopped 7 early.
Glaukos Corporation is based in Aliso Viejo, CA and is listed as NYSE GKOS. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Glaukos Corporation; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-30.
Approve Suite is not affiliated with Glaukos Corporation.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.